Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Acadia Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Acadia_Pharmaceuticals

    Total equity. US$699.14 million (2019) Number of employees. 570 (June 30, 2020) Website. acadia .com. Footnotes / references. [1] Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.

  3. Acadia (ACAD) Upgraded to Buy: What Does It Mean for the Stock?

    www.aol.com/news/acadia-acad-upgraded-buy-does...

    For premium support please call: 800-290-4726 more ways to reach us

  4. Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings ... - AOL

    www.aol.com/news/acadia-pharmaceuticals-acad...

    For premium support please call: 800-290-4726 more ways to reach us

  5. ACADIA Pharmaceuticals Prices Public Offering of Common Stock

    www.aol.com/2013/05/15/acadia-pharmaceuticals...

    ACADIA Pharmaceuticals Prices Public Offering of Common Stock SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (NAS: ACAD) today announced the pricing of an underwritten public offering of ...

  6. Talk:Acadia Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Talk:Acadia_Pharmaceuticals

    Talk. : Acadia Pharmaceuticals. This is the talk page for discussing improvements to the Acadia Pharmaceuticals article. This is not a forum for general discussion of the article's subject. Click here to start a new topic. Assume good faith. Be polite and avoid personal attacks. Be welcoming to newcomers.

  7. Neurocrine Biosciences - Wikipedia

    en.wikipedia.org/wiki/Neurocrine_Biosciences

    Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. [1] The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. [3] Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US ...

  8. M. Michele Burns - Pay Pals - The Huffington Post

    data.huffingtonpost.com/paypals/m-michele-burns

    The M. Michele Burns Stock Index From January 2008 to December 2012, if you bought shares in companies when M. Michele Burns joined the board, and sold them when she left, you would have a 12.9 percent return on your investment, compared to a -2.8 percent return from the S&P 500.

  9. Daniel S. Loeb - Wikipedia

    en.wikipedia.org/wiki/Daniel_S._Loeb

    Daniel Seth Loeb (born December 18, 1961) [1] is an American investor, hedge fund manager, and philanthropist. He is the founder and chief executive of Third Point, a New York-based hedge fund focused on event-driven, value-oriented investing with $4 billion in assets under management, as of December 2023. [2] [3] New York magazine noted that ...